Efficacy of L-threo DOPS on Orthostatic Hypotension Symptoms and Other Non-motor Symptoms in Patients With MSA
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 107 participants.
Also called NCT02071459
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2/3
- Enrolled
- 107 participants
- Registry
-
NCT02071459
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- France
- Registry status
- Completed
Technical summary
Registry record NCT02071459. Randomized; quadruple masking; primary purpose treatment. Start 2014-01-21 (actual); primary completion 2019-10-28 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy of L-threo DOPS on Orthostatic Hypotension Symptoms and Other Non-motor Symptoms in Patients With MSA
- Acronym
- DOPS-AMS
- Condition
- Multiple System Atrophy
- Intervention (Drug)
- L-Threo DOPS
- Intervention (Drug)
- placebo
- Lead sponsor
- University Hospital, Toulouse
Record details
- Record id
cardio:ct-nct02071459- Content hash
d62f1ace358178b1425f97fbd618b19181d3e5434a6bfc8bd5042ef8609f6325